Iron Deficiency in Acute Coronary Syndromes-Clinical Correlates and Outcomes

Gabriele Masini1, Matilde Barsacchi1, Simona Chiusolo1

  • 1Chair and Postgraduate School of Cardiology, University of Pisa and Cardiovascular Division 1, Pisa University Hospital, Pisa, Italy.

PubMed

Insights

Iron deficiency is common in acute coronary syndromes, impacting prognosis. Different definitions reveal varying prevalence and associations with worse left ventricular function and inflammation.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Biochemistry

Background:

  • Iron deficiency is prevalent in heart failure, linked to poor outcomes.
  • Its role in acute coronary syndromes (ACS) remains unclear.
  • This study investigates iron deficiency in ACS patients.

Purpose of the Study:

  • Assess iron deficiency prevalence in ACS patients.
  • Correlate iron deficiency with infarct size and left ventricular function.
  • Examine associations with in-hospital and post-discharge events.

Main Methods:

  • Analyzed 152 ACS patients using multiple iron deficiency criteria.
  • Defined deficiency by serum iron, transferrin saturation (TSAT), ferritin, and combined criteria.
  • Assessed infarct size via peak cardiac troponin T and used Cox regression for event analysis.

Main Results:

  • Iron deficiency prevalence varied from 21% to 62% by definition.
  • Deficiency by serum iron or TSAT correlated with lower ejection fraction, not infarct size.
  • Lower serum iron predicted post-discharge events, though not after hs-CRP adjustment; lower ferritin predicted fewer events.

Conclusions:

  • Iron deficiency is frequent in acute coronary syndromes.
  • Serum iron and TSAT definitions identify patients with poorer left ventricular function and increased inflammation.
  • These factors may influence patient prognosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
431